VivaGel™ (SPL7013 Gel)

A candidate dendrimer - Microbicide for the prevention of HIV and HSV infection

Richard Rupp, Susan L. Rosenthal, Lawrence R. Stanberry

Research output: Contribution to journalArticle

182 Citations (Scopus)

Abstract

Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no commercial product is yet available, many candidates are under development. A leading candidate, VivaGel™ (SPL7013 Gel) is the product of nanotechnology. The active ingredient is SPL7013, a dendrimer that was designed specifically with HIV and HSV antiviral activity and human safety in mind. SPL7013 has demonstrated efficacy against human immunodeficiency virus and herpes simplex virus in in vitro and animal models. VivaGel™ appears to be well tolerated in both animals and humans. This review summarizes the studies of VivaGel™ and its active ingredient, SPL7013.

Original languageEnglish (US)
Pages (from-to)561-566
Number of pages6
JournalInternational Journal of Nanomedicine
Volume2
Issue number4
StatePublished - 2007

Fingerprint

Dendrimers
Anti-Infective Agents
Viruses
HIV Infections
Animals
Gels
Nanotechnology
HIV
Simplexvirus
Sexually Transmitted Diseases
SPL7013
Human Activities
Antiviral Agents
Animal Models
Safety

Keywords

  • Dendrimer
  • Microbicide
  • SPL7013
  • VivaGel™

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Organic Chemistry
  • Drug Discovery

Cite this

VivaGel™ (SPL7013 Gel) : A candidate dendrimer - Microbicide for the prevention of HIV and HSV infection. / Rupp, Richard; Rosenthal, Susan L.; Stanberry, Lawrence R.

In: International Journal of Nanomedicine, Vol. 2, No. 4, 2007, p. 561-566.

Research output: Contribution to journalArticle

@article{0b4ecf282198434a8c4fa25392af5025,
title = "VivaGel™ (SPL7013 Gel): A candidate dendrimer - Microbicide for the prevention of HIV and HSV infection",
abstract = "Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no commercial product is yet available, many candidates are under development. A leading candidate, VivaGel™ (SPL7013 Gel) is the product of nanotechnology. The active ingredient is SPL7013, a dendrimer that was designed specifically with HIV and HSV antiviral activity and human safety in mind. SPL7013 has demonstrated efficacy against human immunodeficiency virus and herpes simplex virus in in vitro and animal models. VivaGel™ appears to be well tolerated in both animals and humans. This review summarizes the studies of VivaGel™ and its active ingredient, SPL7013.",
keywords = "Dendrimer, Microbicide, SPL7013, VivaGel™",
author = "Richard Rupp and Rosenthal, {Susan L.} and Stanberry, {Lawrence R.}",
year = "2007",
language = "English (US)",
volume = "2",
pages = "561--566",
journal = "International Journal of Nanomedicine",
issn = "1176-9114",
publisher = "Dove Medical Press Ltd.",
number = "4",

}

TY - JOUR

T1 - VivaGel™ (SPL7013 Gel)

T2 - A candidate dendrimer - Microbicide for the prevention of HIV and HSV infection

AU - Rupp, Richard

AU - Rosenthal, Susan L.

AU - Stanberry, Lawrence R.

PY - 2007

Y1 - 2007

N2 - Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no commercial product is yet available, many candidates are under development. A leading candidate, VivaGel™ (SPL7013 Gel) is the product of nanotechnology. The active ingredient is SPL7013, a dendrimer that was designed specifically with HIV and HSV antiviral activity and human safety in mind. SPL7013 has demonstrated efficacy against human immunodeficiency virus and herpes simplex virus in in vitro and animal models. VivaGel™ appears to be well tolerated in both animals and humans. This review summarizes the studies of VivaGel™ and its active ingredient, SPL7013.

AB - Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no commercial product is yet available, many candidates are under development. A leading candidate, VivaGel™ (SPL7013 Gel) is the product of nanotechnology. The active ingredient is SPL7013, a dendrimer that was designed specifically with HIV and HSV antiviral activity and human safety in mind. SPL7013 has demonstrated efficacy against human immunodeficiency virus and herpes simplex virus in in vitro and animal models. VivaGel™ appears to be well tolerated in both animals and humans. This review summarizes the studies of VivaGel™ and its active ingredient, SPL7013.

KW - Dendrimer

KW - Microbicide

KW - SPL7013

KW - VivaGel™

UR - http://www.scopus.com/inward/record.url?scp=38949198100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949198100&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 561

EP - 566

JO - International Journal of Nanomedicine

JF - International Journal of Nanomedicine

SN - 1176-9114

IS - 4

ER -